Skip to main content
. 2009 Nov;6(11):S18–S24. doi: 10.1016/j.hrthm.2009.07.020

Table 2.

Blood pressure and HR response to exercise in R92WTNNT2 and MYH7 mutation carriers and noncarrier controls

MYH7 R92WTNNT2 Controls P
Total exercise time, seconds 528 (96–1104) 379 (266–937) 467 (171–1319) .339
MET, kcal/min 6.5 (2.3–12.2) 6.5 (3.9–14.7) 6.2 (2.9–12.1) .660
% HR achieved 96 (74–104) 89 (56–104) 94 (75–108) .417
%CR 88.0 (32.3–141.2) 83.7 (24.8–143.1) 89.4 (54.1–118.5) .487
HRpeak, bpm 171 (129–203) 169 (98–211) 170 (123–197) .449
ΔHR, bpm 92.0 (10–140) 92.0 (28–136) 90.5 (44–137) .499
Abnormal blood pressure response, any (%) 12 (24) 14 (48) 16 (24) .021
Flat (%) 10 (20) 14 (48) 11 (16) .018
Hypotensive (%) 2 (4) 0 (0) 5 (8) .357
SBPpeak, mmHg 160 (120–230) 140 (100–190) 160 (110–220) .064
ΔSBP, mmHg 35 (0–100) 30 (10–60) 40 (5–100) .020
DBPpeak, mmHg 90 (70–120) 90 (50–100) 90 (60–120) .589
ΔDBP, mmHg 10 (−20–40) 10 (−10–30) 10 (−20–40) .732

Note: Values are given as median (range) for continuous variables and as numbers (percentage) for categorical variables. P-values reflect differences between groups for quantile normalized data, adjusted for age, sex, resting mean arterial pressure, and resting HR. Δ = change in parameter between resting and peak exercise; peak = parameter at peak exercise; % HR achieved = % of predicted maximal HR achieved by peak exercise.